1. Orthofix and SeaSpine’s merger was completed Jan. 5.Ninety-nine percent of SeaSpine common shares were voted in approval of the merger, and 98% of Orthofix common shares were voted in approval.
2. Orthofix saw year-over-year revenue growth in the first, second and third quarters of 2023.
3. Orthofix has a new CEO — Massimo Calafiore. He will step into the role in 2024 to replace interim CEO Catherine Burzik. The company is still looking to replace its interim CFO and interim chief legal officer.
4. Orthofix had several notable spine product launches including the WaveForm L interbody system, OsteoCove advance bioactive synthetic graft and WaveForm A interbody device.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
